With the understanding that Bortezomib induces an oxidative stress response, we treated MM cells with additional oxidative stressors, such as As[III] and H2O2, and assessed SQSTM1 oligomerization through immunofluorescence staining. The gene discussed is SQSTM1; the disease is Miyoshi myopathy.